Arrowstreet Capital

Arrowstreet Capital’s Niagen Bioscience NAGE Stock Holding History

Arrowstreet Capital’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.5M	Buy	2,378,437 +761,685	+47%	+$4.11M	0.01%	931
2025 Q4	$10.3M	Buy	1,616,752 +179,954	+13%	+$1.25M	0.01%	919
2025 Q3	$13.4M	Buy	1,436,798 +317,418	+28%	+$3.2M	0.01%	864
2025 Q2	$16.1M	Buy	1,119,380 +129,507	+13%	+$1.28M	0.01%	756
2025 Q1	$6.83M	Buy	989,873 +326,917	+49%	+$2.05M	0.01%	917
2024 Q4	$3.52M	Buy	662,956 +492,148	+288%	+$2.69M	﹤0.01%	1113
2024 Q3	$623K	Buy	+170,808	New	+$538K	﹤0.01%	1484

Other funds holding NAGE

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.8B AUM 48.92% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return

Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return

UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM